Abstract. The effects of a-and -interferons (IFNs) on collagen production by confluent human diploid fibroblasts in culture were examined. It was found that partially purified a-IFNs and affinity purified -y-IFNs caused >50% inhibition of collagen synthesis by these cells independently of their effect on cell proliferation. Recombinant a-IFNs showed a similar effect (38.8% inhibition), indicating that collagen synthesis inhibition was a constitutive property of IFNs. Collagen synthesis inhibition by IFNs was concentration dependent. Gel filtration chromatography of the newly synthesized proteins from the media of fibroblasts incubated with partially purified a-IFNs demonstrated a selective depression of molecules eluting in the region of procollagen. No detectable increase in collagen degradation products or underhydroxylation of procollagen was observed. Short-term kinetic studies further demonstrated that the major effect of IFNs was due to a net decrease in fibroblast collagen production rather than to impairment of secretion or increased extracellular degradation of the newly synthesized molecules. These results indicate that a-and -y-IFNs are potent inhibitors of human fibroblast collagen production and suggest that they may play an important role in the regulation of normal and pathologic fibrogenesis.
. Abnormalities in collagen regulation may be responsible for the excessive and frequently progressive fibrosis characteristic of certain diseases such as scleroderma (2) . Collagen production can be controlled by three general mechanisms: modulation of the steady state level of messenger RNA (mRNA); control of mRNA translation; and variation in the fraction of collagen that is degraded intracellularly (1) . In addition to these intrinsic mechanisms of control, extrafibroblastic factors may influence the rates of collagen synthesized by these cells. For example, the role of inflammatory cells on the regulation of fibroblast proliferation and collagen synthesis has recently been emphasized (3) (4) (5) (6) (7) (8) . Interest in the study of this possible mechanism of fibroblast regulation has been stimulated by the frequent observation of a proximity of inflammatory cells and fibroblasts in tissues undergoing active collagen deposition. It has been previously shown that interferons (IFNs)' can influence the proliferation of various fibroblastic cell lines (for review see reference 9) . The possibility that IFNs may be able to modulate fibroblast collagen synthesis independently of their effects on cell proliferation, however, has not been examined. In the present work, we have studied the effects of various IFN preparations on collagen synthesis, employing confluent dermal fibroblasts to dissociate the antiproliferative effects of IFNs from those related to regulation of collagen synthesis in stationary-phase cells. We found that both a-and y-IFNs caused a concentration-dependent inhibition of collagen synthesis by normal human diploid fibroblasts. These results suggest that IFN may play an important role in the regulation of collagen production, particularly under pathologic conditions characterized by an accumulation of inflammatory cells in the affected tissues.
Methods
Partially purified a-IFNs (IF-2810), various preparations of a-IFN purified to homogeneity by high pressure liquid chromatography (HPLC) (IL-b, IL-c, IL-d, and IL-null) as described in detail elsewhere 1. Abbreviations used in this paper: aff-IFN-'y, affinity-purified 'yinterferon; HPLC, high performance liquid chromatography; IFN, interferon; IFN-A, recombinant a-!FN(A); PMSF, paramethylsulfonyl fluoride. (10) , and a preparation of recombinant a-IFN(A) (IFN-A) were kindly supplied to us by Dr. Sidney Petska (Hoffmann-LaRoche, Inc., Nutley, NJ). All preparations were standardized to contain 1,000 U/ml of antiviral activity (11) . A preparation of affinity-purified 'y-IFN (aff-IFN--y) was purchased from Interferon Sciences, Inc. (New Brunswick, NJ) and was also standardized to contain 1,000 U/mI of antiviral activity, based on the information about activity given by the manufacturer.
Fibroblast cultures and labeling conditions. Fibroblasts were obtained from skin biopsies from normal individuals, as described previously (12) , and were cultured in modified Eagle's medium supplemented with 10% fetal calf serum in an atmosphere of 5% CO2 for 5 gg/ml PMSF, and the solutions were heated and dialyzed as described for the media. The amount of radioactive hydroxyproline synthesized by the cultured fibroblasts was measured by a specific chemical assay (13) . In certain experiments both media and cell layers were analyzed, but in most cases only the culture media were studied since, as shown previously, >80% of total collagen synthesized by the control or experimental cultures was released into the media under the conditions employed (5).-Short-term labeling offibroblast cultures. In order to examine the effects of the IFNs on the kinetics of collagen synthesis and secretion, short-term labeling experiments were performed. For this purpose, confluent fibroblasts were incubated under control conditions or in the presence of 1,000 U/mi of aff-IFN-'y exactly as described above, and after 2 d they were labeled by the addition of 5 MCi/ml ['4C]proline to the culture media. Two plates from each set were harvested at 1, 3, and 6 h after labeling, and the media and cell layers were separated and processed as described above for the cultures labeled for 24 h.
Gelfiltration. Chromatography of labeled proteins from the media and cell layers of control and IFN-treated cultures was performed on 1.5 X 85 cm columns of agarose A-5m, 200 to 400 mesh (Bio-Rad Laboratories, Richmond, CA) as previously described (12 Cultures of confluent human diploid fibroblasts were incubated in control medium or in medium containing 1,000 U/ml of the various IFN preparations and processed as described in Table I Dose-response studies. To determine if the effects of IFN were dose dependent, various concentrations ranging from 0 to 1,000 U/ml of partially purified a-IFN, IFN-A, and aff-IFN-y were tested. The results shown in Fig. 1 demonstrate that increasing concentrations of the three IFN preparations caused a progressive inhibition of fibroblast collagen production. The aff-IFN-'y was the most potent since it caused a 50% inhibition of collagen biosynthesis at a concentration of only 100 U/ml, and maximum inhibition (72%) was observed at a concentration of 500 U/ml. The partially purified a-IFN was less potent, since a concentration of 500 U/ml was required to produce a 50% decrease in ["4C]hydroxyproline synthesis, and the maximal inhibition observed was only 55%. The preparation of IFN-A showed less inhibitory effect since a significant inhibition (22%) was demonstrated only at the highest concentration tested (1,000 U/ml).
Chromatography of labeled proteins. SDS-agarose chromatography of the labeled proteins from the media of control cultures and from cultures labeled in the presence of 1,000 U/ ml of partially purified a-IFN is shown in Fig. 2 . In the chromatogram from control medium, a predominant peak containing >50% of the total radioactivity was found in the position of elution of standard dermal fibroblast procollagen (peak B). The remaining radioactivity was found in three other peaks of varying molecular weight (peaks A, C, and D). In contrast, in the sample from the IFN-treated culture, only 17% of the radioactivity in the chromatogram was in the procollagen peak. To identify the collagenous proteins in the chromatograms and to determine their degree of hydroxylation, four regions of each chromatogram were pooled as indicated in Fig. 2 (367 dpm in control vs. 323 dpm in IFN-treated samples). These results indicate that the decrease in collagen production caused by IFN was not due to underhydroxylation or increased extracellular degradation of the newly synthesized collagen.
Effects ofIFN on the short-term kinetics ofcollagen synthesis and secretion. To document further that the observed IFN effects were due to inhibition of collagen production rather than to extracellular degradation of the newly synthesized collagen, control or IFN-treated cultures were labeled for 1, 3, media also displayed a linear increase with time under both experimental conditions, but it was substantially lower in the IFN-treated cultures at all time intervals studied. These results further demonstrate that the effect of IFN was due to an inhibition of net fibroblast collagen production and that the impairment of collagen secretion or increased extracellular degradation of the newly synthesized molecules did not significantly contribute to the overall IFN effects.
Discussion
The proximity of inflammatory cells with fibroblasts in areas of repair and early fibrosis has been noticed for some time, and the possibility that inflammatory cells can regulate fibroblast function has been given recent experimental attention (3) (4) (5) (6) (7) (8) .
Of the various factors produced by inflammatory cells, IFNs have been some of the most extensively studied and characterized. In addition to their well known antiviral activity, IFNs can exert potent antiproliferative effects on a variety of cells, including fibroblasts (for review see reference 9). The results described here show that IFNs can inhibit collagen production by normal human diploid fibroblasts independently of any influence on cell replication. From the several IFN preparations studied, the most potent inhibitory effects (up to 72% inhibition) were observed with aff-IFN-y. The partially purified a-IFN was slightly less effective, although at higher concentrations it caused almost 60% inhibition of ['4C]hydroxyproline synthesis. In contrast, the preparations of HPLC-purified a-IFN were ineffective or caused only minor inhibition (<31% with 1,000 U/ml). Although the IFN-A showed substantially less collagen synthesis inhibitory activity than did the partially purified preparation, the observation that recombinant IFN molecules caused inhibition of fibroblast collagen synthesis indicates that this is a constitutive property of IFNs.
The marked decrease in collagen production by fibroblasts caused by IFNs did not appear to be due to underhydroxylation, impairment of secretion, or increased extracellular degradation of this macromolecule. From the present studies, however, it is impossible to determine if these effects reflect transcriptional or translational control of collagen synthesis or increased intracellular collagen degradation. Regardless ofthe mechanisms responsible for the IFN-induced decrease in fibroblast collagen production, our findings suggest that IFNs may play an important role in the regulation of collagen production.
Our results may also explain, at least in part, the observation that inflammatory reactions secondary to viral infections are not usually accompanied by significant tissue fibrosis. It can be hypothesized that in these circumstances, the high levels of IFNs produced may result in an inhibition of fibroblast proliferation as well as of collagen synthesis by these cells. On the other hand, it is tempting to speculate that alterations in IFN regulation or decreased sensitivity of fibroblasts to the modulatory effects of IFNs may play a role in the excessive and frequently progressive fibrosis observed in certain diseases associated with tissue infiltration by immunocompetent cells, such as scleroderma or idiopathic pulmonary fibrosis. In this regard it is interesting that y-IFN, which may be produced during an immune response, was the most potent inhibitor of collagen synthesis. Finally, the marked inhibition of collagen production observed in fibroblast cultures incubated with relatively small concentrations of IFNs suggests the possibility that IFNs can be used as therapeutic agents to prevent the excessive fibrotic response frequently associated with these diseases.
